Piramal Pharma Share price

PPLPHARMA

Healthcare Large

202.37

1.23 (-0.60%)

NSE

BSE

Last updated on 24 Oct, 2025 | 15:45 IST

BUYSELL

Today's High

206.50

Today's Low

201.77

52 Week Low

181.73

52 Week High

307.90 The current prices are delayed, login to your account for live prices

Piramal Pharma Share Key Metrics

Volume

31.69 L

Market Cap

26899.99 CR

LTQ@LTP

2@202.37

ATP

204.27 Var Margin

19.42 %

Circuit Range

183.24-223.96

Delivery %

39.88 %

Value

64.73 CR

ASM/GSM

No

Market Lot

1

Piramal Pharma Fundamentals

P/E Ratio

274.13

P/B Ratio

3.37

Div. Yield

0.07

Sector P/E

37.45

Sector P/B

3.53

Sec. Div. Yield

0.55

Piramal Pharma Resistance and Support

Pivot 192.24

Resistance

First Resistance

194.48

Second Resistance

196.93

Third Resistance

199.17

Support

First Support

189.79

Second Support

187.55

Third Support

185.1

Piramal Pharma Futures & Options

PPLPHARMA-EQ

202.37 -1.23 (-0.6%)

Piramal Pharma Option Chain

View Price, OI, Greeks & More...

View All

28OCT25

202.60 -1.64 (0.80%)

25NOV25

203.16 -1.52 (0.74%)

30DEC25

204.15 -1.40 (0.68%)

PPLPHARMA|28OCT25 CE 200.00

3.50 -1.5 (-30%)

PPLPHARMA|28OCT25 PE 202.50

1.95 0.3 (18.18%)

Piramal Pharma Shareholding Pattern

2022-23
2023-24
2024-25
2025-26

Total Promoters

Segment

Percent

Total Promoters

34.86%

Mutual Fund

13.11%

Insurance

1.49%

Foreign Institutional Investors

30.27%

Domestic Institutional Investors

0.29%

Retail

19.98%

Others

0%

Total Promoters

MAR '25

34.95%

JUN '25

34.86%

SEP '25

34.86%

Piramal Pharma Corporate Actions

Date	Agenda
2025-07-28	Quarterly Results
2025-05-14	Audited Results & Final Dividend
2025-01-28	Quarterly Results
2024-10-23	Quarterly Results

Piramal Pharma News

Piramal Pharma stock surges 5.5% on solid Q2 earnings show

Oct 24 2024 09:51:53

Piramal Pharma Q2 Results: Net profit jumps over 4-fold to Rs 23 cr; revenue at Rs 2,242 cr

Oct 24 2024 12:12:03

Piramal Pharma to pay USD 407,400 to US-based VetDC Inc to settle dispute

Dec 06 2024 19:51:50

Stocks to buy today: Vedanta, ITC and Piramal Pharma on investors' radar

Dec 18 2024 07:36:53

NSE : 11571

BSE : 543635

ISIN : INE0DK501011

Piramal Pharma Management

Name	Position
Mrs. Nandini Piramal	Chairperson
Mr. Peter DeYoung	Executive Director

Piramal Pharma Similar Stocks

Ajanta Pharma Ltd.

2414.40

-0.10 (0.00%)

Krishna Institute of Medical Sciences Ltd

719.90

-0.30 (0.04%)

JB Chemicals & Pharmaceuticals Ltd.

1702.20

-6.60 (0.39%)

Emcure Pharmaceuticals Ltd.

1357.30

-27.70 (2.00%)

Dr. Lal Pathlabs Ltd.

3048.20

-23.50 (0.77%)

Pfizer Ltd.

5325.50

28.00 (0.53%)

Wockhardt Ltd.

1332.40

-26.40 (1.94%)

Eris Lifesciences Ltd.

1582.60

-7.00 (0.44%)

Onesource Specialty Pharma Ltd.

1841.00

0.20 (0.01%)

Neuland Laboratories Ltd.

15991.00

-207.00 (1.28%)

Piramal Pharma FAQs

The Buying Price of Piramal Pharma share is 202.37 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 274.13. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Piramal Pharma shares is 3.37. Useful to assess the stock's value relative to its book value.

To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 37.45 & 3.53 with sector averages, along with growth rates and financial metrics.

The Market Cap of Piramal Pharma is 26899.99 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Piramal Pharma share price is 307.90 & 181.73. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Piramal Pharma belongs to the Healthcare sector.